GALAXY

Gut-and-Liver Axis in Alcoholic Liver Fibrosis

What is GALAXY?

GALAXY is a H2020 project that aims to optimize personalized healthcare for patients with liver disease,

by stratifying individuals who would benefit from targeted healthcare efforts versus those who would not,

and thus to reduce the economic burden for health care systems and to improve health outcome for the patients.

GALAXY has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 668031

Latest News

08.04.2021

Hepatology for Dummies

7 April, the first Academy Afternoon in the GALAXY and MicrobLiver consortia was hosted by Odense University Hospital.

Read article

16.03.2021

PhD defence Ditlev Nytoft Rasmussen

26 March, Ditlev Nytoft Rasmussen will defend his PhD on prognostic markers in alcohol-related liver disease.

Read article

11.03.2021

GALAXY online meeting

1-3 March, GALAXY hosted a 3 days online meeting for all partners together with project MicrobLiver

Read article

25.01.2021

Multinational collaboration establish common cut-offs for liver stiffness measurements

Finally, researchers have agreed on the interpretation of liver stiffness measurements. There has long been disagreement about which cut-off values to use for transient elastography (FibroScan). With the use of GALAXY data, a multinational collaboration has now established cut-off values to rule in and rule out compensated advanced chronic liver disease across the four major liver disease etiologies.

Read article

Inclusion of patients

20.01.2021

Inclusion of patients concluded in the fourth GALAXY study

55 patients with alcoholic liver disease are now included in the SYN-ALD a randomized controlled trial in GALAXY.

Read article

04.12.2020

GALAXY part of multi-centre study published in AP&T

New study shows that digital assistance improves physician’s accuracy to predict who will develop complication to cirrhosis and die from alcohol-related liver disease.

Read article

GALAXY publications

03.09.2020

ILC2020

Five abstracts from the GALAXY project was presented on 27-29 August at the Digital International Liver Congress 2020

Read article

GALAXY Clinical Trials

15.05.2020

136 ALD patients included in the Rifaximin trial

In May 2020 an important milestone in the Rifaximin study was reached, since the last of 136 participants was included.

Read article

GALAXY events

23.03.2020

GALAXY Steering Committee Meeting

The GALAXY partners met in Copenhagen for Steering Committee Meeting

Read article

GALAXY publications

18.11.2019

Best of the Liver Meeting 2019

GALAXY had two oral presentations at the Liver Meeting 2019 - one was selected as part of Best of Liver Meeting 2019

Read article

09.11.2019

GALAXY Advisory Board

GALAXY hosted meeting at AASLD in Boston

Read article

Meet the companies and research groups behind GALAXY

Get news about GALAXY on Twitter

What drives and inspires a young investigator? Read the portraits of the young investigators in GALAXY!

Status of the GALAXY project

Get insight information about what has happened in the GALAXY project in the third period.

Link to the report!

What are the advantages of screening for ALD? Presentation by Maja Thiele at ILC2019!

GALAXY publications

Link to publication list